How much cash does Takeda Pharmaceutical have?

According to Takeda Pharmaceutical's latest annual financial reports, the company has a total of $457.80B in cash and cash equivalents. This amount includes all liquid assets that can be readily converted into cash.

Additionally, Takeda Pharmaceutical holds $15.09B in short-term investments, which are highly liquid assets that can be easily converted into cash within a short period.

In total, the company has $457.80B when combining cash and cash equivalents with short-term investments.

On a per-share basis, Takeda Pharmaceutical has $302.27 in cash. This metric helps investors understand how much cash the company holds per outstanding share.

The company's free cash flow, which is the cash generated from operations after deducting capital expenditures, stands at $235.61B. This is an important indicator of financial health, showing the cash available for distribution to shareholders or reinvestment into the company.

Lastly, the company's cash position has experienced a growth rate of -14.19%, reflecting the increase in cash and cash equivalents over the specified period.

Takeda Pharmaceutical Historical Cash on Hand

Cash on Hand History

The table below shows the amount of cash on hand for each year, with the latest data available for the last fiscal year 2023.

Year	Cash on Hand	Change
2023	$457.80B	-14.19%
2022	$533.53B	-37.21%
2021	$849.70B	-12.06%
2020	$966.22B	51.54%
2019	$637.61B	-9.18%
2018	$702.09B	138.38%
2017	$294.52B	-7.80%
2016	$319.45B	-29.23%
2015	$451.43B	-30.78%
2014	$652.15B	-2.09%
2013	$666.05B	129.98%
2012	$289.61B	-36.24%
2011	$454.25B	108.47%
2010	$217.90B	-18.25%
2009	$266.54B	16.12%
2008	$229.53B	-85.77%
2007	$1.61T	-2.09%
2006	$1.65T	1.32%
2005	$1.63T	28.62%
2004	$1.26T	17.49%
2003	$1.08T	5.19%
2002	$1.02T	35.79%
2001	$753.32B	18.75%
2000	$634.38B	N/A